» Articles » PMID: 38781160

Spectrum of Infection and Outcomes in Individuals with Candida Auris Infection in Qatar

Abstract

Background: We investigated the spectrum of infection and risk factors for invasive fungal disease due to Candida auris (CA) in Qatar.

Methods: We performed structured chart reviews on individuals with any positive CA culture between May 2019 and December 2022 at three tertiary care hospitals in Qatar. Invasive CA disease (ICAD) was defined as a positive sterile site culture, or any positive culture for CA with appropriate antifungal prescription. Main outcomes included proportion of individuals who developed ICAD among those with positive cultures, and 30-day/in-hospital mortality.

Results: Among 331 eligible individuals, median age was 56 years, 83.1% were male, 70.7% were non-Qataris, and 37.5% had ≥ 3 comorbidities at baseline. Overall, 86.4% were deemed to have colonization and 13.6% developed ICAD. Those with ICAD were more likely to have invasive central venous or urinary catheterization and mechanical ventilation. Individuals with ICAD had longer prior ICU stay (16 vs 26 days, P = 0.002), and longer hospital length of stay (63 vs. 43 days; P = 0.003), and higher 30-day mortality (38% vs. 14%; P<0.001). In multivariable regression analysis, only mechanical ventilation was associated with a higher risk of ICAD (OR 3.33, 95% CI 1.09-10.17).

Conclusion: Invasive Candida auris Disease is associated with longer hospital stay and higher mortality. Severely ill persons on mechanical ventilation should be especially monitored for development of ICAD.

Citing Articles

Independent introductions and nosocomial transmission of in Saudi Arabia ─ a genomic epidemiological study of an outbreak from a hospital in Riyadh.

Guan Q, Alasmari F, Li C, Mfarrej S, Mukahal M, Arold S Microbiol Spectr. 2025; 13(3):e0326024.

PMID: 39903450 PMC: 11878057. DOI: 10.1128/spectrum.03260-24.

References
1.
Ben Abid F, Salah H, Sundararaju S, Dalil L, Abdelwahab A, Salameh S . Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs. Clin Microbiol Infect. 2023; 29(8):1083.e1-1083.e7. PMC: 10132836. DOI: 10.1016/j.cmi.2023.04.025. View

2.
Alothman A, Al-Musawi T, Al-Abdely H, Salman J, Almaslamani M, Yared N . Clinical practice guidelines for the management of invasive Candida infections in adults in the Middle East region: Expert panel recommendations. J Infect Public Health. 2013; 7(1):6-19. DOI: 10.1016/j.jiph.2013.08.002. View

3.
Salah H, Sundararaju S, Dalil L, Salameh S, Al-Wali W, Tang P . Genomic Epidemiology of in Qatar Reveals Hospital Transmission Dynamics and a South Asian Origin. J Fungi (Basel). 2021; 7(3). PMC: 8004815. DOI: 10.3390/jof7030240. View

4.
Du H, Bing J, Hu T, Ennis C, Nobile C, Huang G . Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020; 16(10):e1008921. PMC: 7581363. DOI: 10.1371/journal.ppat.1008921. View

5.
Thomas-Ruddel D, Schlattmann P, Pletz M, Kurzai O, Bloos F . Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis. Chest. 2021; 161(2):345-355. PMC: 8941622. DOI: 10.1016/j.chest.2021.08.081. View